BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 443651)

  • 1. Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
    Durant JR; Norgard MJ; Murad TM; Bartolucci AA; Langford KH
    Ann Intern Med; 1979 Feb; 90(2):191-4. PubMed ID: 443651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.
    Selker RG; Jacobs SA; Moore PB; Wald M; Fisher ER; Cohen M; Bellot P
    Neurosurgery; 1980 Dec; 7(6):560-5. PubMed ID: 7207751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].
    Schreml W; Bargon G; Anger B; Kubanek B; Heimpel H
    Blut; 1978 Jun; 36(6):353-6. PubMed ID: 656638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Sweet DL
    Ann Intern Med; 1979 Jul; 91(1):132-3. PubMed ID: 464443
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Stillerman R
    Ann Intern Med; 1979 Jul; 91(1):132. PubMed ID: 464442
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Ryan BR; Walters TR
    Cancer; 1981 Aug; 48(4):909-11. PubMed ID: 7272934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Kaplan RL
    Ann Intern Med; 1979 Jul; 91(1):131. PubMed ID: 464440
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU).
    Weiss RB; Muggia FM
    Ann Intern Med; 1979 Jul; 91(1):131-2. PubMed ID: 464441
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.
    Richter JE; Hastedt R; Dalton JF; Marshall D; Raymond LW
    Cancer; 1979 May; 43(5):1607-12. PubMed ID: 445356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible pulmonary toxicity after single course of BCNU.
    Lieberman A; Ruoff M; Estey E; Seidman I; Lieberman I; Wise A
    Am J Med Sci; 1980; 279(1):53-6. PubMed ID: 7369249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early pulmonary toxicity after administration of high-dose BCNU.
    Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
    Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary toxicity from carmustine (BCNU): a case report.
    Weiss RB; Shah S; Shane SR
    Med Pediatr Oncol; 1979; 6(3):255-9. PubMed ID: 470840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
    O'Driscoll BR; Hasleton PS; Taylor PM; Poulter LW; Gattameneni HR; Woodcock AA
    N Engl J Med; 1990 Aug; 323(6):378-82. PubMed ID: 2370889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced pulmonary toxicity.
    Cazzadori A; Braggio P; Barbieri E; Ganassini A
    Respiration; 1986; 49(2):157-60. PubMed ID: 3952381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary toxicity in long-term administration of BCNU.
    Holoye PY; Jenkins DE; Greenberg SD
    Cancer Treat Rep; 1976 Nov; 60(11):1691-4. PubMed ID: 1021241
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Melato M; Tuveri G
    Cancer; 1980 Mar; 45(6):1311-4. PubMed ID: 7357522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
    Suratt BT; Lynch DA; Cool CD; Jones RB; Brown KK
    Bone Marrow Transplant; 2003 May; 31(10):939-41. PubMed ID: 12748674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea.
    Crittenden D; Tranum BL; Haut A
    Chest; 1977 Sep; 72(3):372-3. PubMed ID: 891293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.
    Hasleton PS; O'Driscoll BR; Lynch P; Webster A; Kalra SJ; Gattamaneini HR; Woodcock AA; Poulter LW
    J Pathol; 1991 May; 164(1):31-6. PubMed ID: 2056387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
    Parish JM; Muhm JR; Leslie KO
    Mayo Clin Proc; 2003 May; 78(5):630-4. PubMed ID: 12744552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.